Cargando…

Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and NUP214-ABL1 fusion: A case report

The present study aimed to evaluate the therapeutic efficacy of dasatinib in a patient with nucleoporin 214-tyrosine protein kinase ABL1 proto-oncogene 1 (NUP214-ABL1)-positive early T-cell precursor-acute lymphoblastic leukemia (ETP-ALL), as well as that of selinexor and dasatinib for NUP214-ABL1-p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yan, Zhang, Li, Huang, Jiankun, Hong, Xiuli, Zhao, Jiangning, Wang, Zhao, Zhang, Kejie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647690/ https://www.ncbi.nlm.nih.gov/pubmed/29067094 http://dx.doi.org/10.3892/etm.2017.5046

Ejemplares similares

SET-NUP214 Fusion Gene Involved Early T-Cell Precursor Acute Lymphoblastic Leukemia in Adult with B Marker Expression
por: Xu, Xiaoying, et al.
Publicado: (2021)

NUP214 fusion genes in acute leukemia (Review)
por: ZHOU, MIN-HANG, et al.
Publicado: (2014)

SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines
por: Quentmeier, Hilmar, et al.
Publicado: (2009)

Detection of a cryptic NUP214/ABL1 gene fusion by mate-pair sequencing (MPseq) in a newly diagnosed case of pediatric T-lymphoblastic leukemia
por: Peterson, Jess F., et al.
Publicado: (2019)

Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia
por: Simioni, Carolina, et al.
Publicado: (2016)

Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion
por: Stukaite-Ruibiene, Egle, et al.
Publicado: (2022)

Detection of NUP214-ABL1 translocation using BCR-ABL1 dual color FISH probes in T-cell acute lymphoblastic leukemia–an illustrative report and review of literature
por: Virk, Harpreet, et al.
Publicado: (2022)

Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy
por: Nardi, Valentina, et al.
Publicado: (2022)

Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia
por: Fei, Fei, et al.
Publicado: (2010)

Targeted CRM1-inhibition perturbs leukemogenic NUP214 fusion proteins and exerts anti-cancer effects in leukemia cell lines with NUP214 rearrangements
por: Mendes, Adélia, et al.
Publicado: (2020)

Case Report: The First Report of NUP214-ABL1 Fusion Gene in Acute Myeloid Leukemia Patient Detected by Next-Generation Sequencing
por: Wang, Huan-Ping, et al.
Publicado: (2021)

SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances
por: Song, Jingyu, et al.
Publicado: (2023)

NUP214 in Leukemia: It’s More than Transport
por: Mendes, Adélia, et al.
Publicado: (2019)

Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia
por: Vanden Bempt, Marlies, et al.
Publicado: (2018)

A Rare Case of Acute Myeloid Leukemia With SET-NUP214 Fusion and Massive Hyperdiploidy
por: Jeong, In Hwa, et al.
Publicado: (2019)

The outcome of acute leukemia patients with SET-NUP214 fusion after allogeneic stem cell transplantation
por: Shen, Yuyan, et al.
Publicado: (2023)

Prognostic significance of SET-NUP214 fusion gene in acute leukemia after allogeneic hematopoietic stem cell transplantation
por: Gao, Meng-Ge, et al.
Publicado: (2020)

Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With SET-CAN/NUP214 Fusion: Perspectives From a Case Report and Literature Review
por: Lin, Na, et al.
Publicado: (2021)

BCR/ABL1-positive B-lymphoblastic Lymphoma Successfully Treated with Dasatinib-combined Chemotherapy
por: Yamada, Chika, et al.
Publicado: (2021)

Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach
por: Mendes, Adélia, et al.
Publicado: (2020)

Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition
por: Xiao, Xinhua, et al.
Publicado: (2020)

Distinct functions of the Drosophila Nup153 and Nup214 FG domains in nuclear protein transport
por: Sabri, Nafiseh, et al.
Publicado: (2007)

The characteristics and prognostic significance of the SET-CAN/NUP214 fusion gene in hematological malignancies: A systematic review
por: Wang, Jing, et al.
Publicado: (2022)

Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR
por: Sandén, Carl, et al.
Publicado: (2013)

Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion
por: Decool, Gauthier, et al.
Publicado: (2019)

Nup84, A Novel Nucleoporin That Is Associated With CAN/Nup214 on the Cytoplasmic Face of the Nuclear Pore Complex
por: Bastos, Ricardo, et al.
Publicado: (1997)

Dasatinib‐induced hypoglycemia in a patient with acute lymphoblastic leukemia
por: Lundholm, Michelle D., et al.
Publicado: (2020)

Nuclear Distributions of NUP62 and NUP214 Suggest Architectural Diversity and Spatial Patterning among Nuclear Pore Complexes
por: Kinoshita, Yayoi, et al.
Publicado: (2012)

Entire ABL1 Gene Deletion Without BCR/ABL1 Rearrangement in a Female Patient with B-Cell Precursor Acute Lymphoblastic Leukemia
por: Jiang, Yijing, et al.
Publicado: (2020)

Dasatinib-induced reversible pulmonary arterial hypertension in a pediatric patient with BCR/ABL1+ lymphoblastic lymphoma from chronic myeloid leukemia
por: Han, Hye-ji, et al.
Publicado: (2022)

Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion
por: Dai, Hai-Ping, et al.
Publicado: (2020)

Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia
por: Sarno, Jolanda, et al.
Publicado: (2023)

A Novel Translocation: t(2;14)(p12;q32) in a Case of Precursor B-acute Lymphoblastic Leukemia
por: Sampathkumar, Prasannakumari, et al.
Publicado: (2017)

Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia
por: Boer, Judith M., et al.
Publicado: (2016)

Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia
por: Kim, Jaeseung C., et al.
Publicado: (2023)

Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
por: Cerchione, Claudio, et al.
Publicado: (2021)

Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia
por: Scherr, Michaela, et al.
Publicado: (2018)

Nucleocytoplasmic shuttling by nucleoporins Nup153 and Nup214 and CRM1-dependent nuclear export control the subcellular distribution of latent Stat1
por: Marg, Andreas, et al.
Publicado: (2004)

The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice
por: Lavau, Catherine P., et al.
Publicado: (2020)

Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice
por: Kundu, Subhadip, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_im0u95ft3hde8g8f98brf5p41p